TFMPP and
m-CPP, non-selective
5-HT agonists, administered in doses of 1-20 mg/kg evoked
hyperthermia in rats at a high ambient temperature (28 degrees C). The hyperthermic effect of
TFMPP (10 mg/kg) or
m-CPP (10 mg/kg) was dose-dependently antagonized by the 5-HT1c and 5-HT2 receptor antagonists
mesulergine (0.5-4 mg/kg),
ketanserin (0.6-2.5 mg/kg) and
ritanserin (0.5-2 mg/kg) and by the non-selective
5-HT antagonist metergoline (0.5-1 mg/kg), or was attenuated by the 5-HT1A, 5-HT2 and
dopamine receptor antagonist spiperone (3 mg/kg, but not 0.3 or 1 mg/kg). On the other hand, the 5-HT1A, 5-HT1B and
beta adrenoceptor antagonists pindolol (2 mg/kg) and
cyanopindolol (2 mg/kg), the
5-HT1A receptor agonist/antagonist
ipsapirone (10 and 35 mg/kg) and
haloperidol (0.25 and 0.5 mg/kg) showed a tendency towards enhancing the
TFMPP- or
m-CPP-
induced hyperthermia. The 5-HT1A and alpha 1-adrenoceptor antagonist
NAN-190 (1-4 mg/kg), the
5-HT3 antagonists tropisetron (0.01-1 mg/kg) and
zacopride (0.5 and 1 mg/kg), the beta-blockers
betaxolol (8 mg/kg) and ICI 118, 551 (8 mg/kg), which have no affinity for
5-HT receptors and
prazosin (1 mg/kg), did not affect the hyperthermic effect of
TFMPP or
m-CPP. The
hyperthermias studied were not modified, in animals with
5-HT lesion produced by
p-chloroamphetamine (PCA) either. All the drugs used as putative receptor antagonists, as well as PCA, did not change or decreased (
ipsapirone) the body temperature in heat-adapted rats.(ABSTRACT TRUNCATED AT 250 WORDS)